Last week, RNL Bio issued a press release announcing that the company has filed an Investigational New Drug application with the Korea Food and Drug Administration. According to the press release, RNL Bio wants to conduct a “Phase II/III” clinical…
Last week, RNL Bio issued a press release announcing that the company has filed an Investigational New Drug application with the Korea Food and Drug Administration. According to the press release, RNL Bio wants to conduct a “Phase II/III” clinical…